Simona Songia

Minimal residual disease before and after transplantation for childhood acute lymphoblastic leukaemia: is there any room for intervention?

Adriana Balduzzi, Lucia Di Maio, Daniela Silvestri et al. · British Journal of Haematology · 2014 · 91 citations · Full text

Characterization of the new immunosuppressive drug undecylprodigiosin in human lymphocytes: retinoblastoma protein, cyclin-dependent kinase-2, and cyclin-dependent kinase-4 as molecular targets

Simona Songia, Alessandra Mortellaro, Stefano Taverna et al. · The Journal of Immunology · 1997 · 89 citations

New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.

Alessandra Mortellaro, Simona Songia, Paola Gnocchi et al. · PubMed · 1999 · 86 citations

Cell Cycle Analysis, T-regulatory Cell, Immune Regulation +21

New Immunosuppressive Drug PNU156804 Blocks IL-2-Dependent Proliferation and NF-κB and AP-1 Activation

Alessandra Mortellaro, Simona Songia, Paola Gnocchi et al. · The Journal of Immunology · 1999 · 78 citations · Full text

Cell Cycle Analysis, Immune Regulation, Immunology +23

Pre‐ and post‐transplant minimal residual disease predicts relapse occurrence in children with acute lymphoblastic leukaemia

Federica Lovisa, Marco Zecca, Bartolomeo Rossi et al. · British Journal of Haematology · 2018 · 61 citations · Full text